Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Chemed (CHE)

Chemed's VITAS completes $85 million Covenant hospice asset purchase in Florida, Alabama

Neutral Impact 3 of 5 m&a Written later

VITAS Healthcare, a wholly owned subsidiary of Chemed, completed its $85 million purchase of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, effective April 17, 2024. The purchase was made with cash on hand, and the filing does not report financial results from the acquired operations.

Key points

  • Purchase price: $85 million, structured as an asset purchase, funded with cash on hand
  • Covenant hospice operations span the Florida panhandle and Alabama, including Pensacola, Tallahassee, Panama City and Dothan markets
  • Transaction was first announced on March 13, 2024 and closed effective April 17, 2024

The filing

CompanyChemed (CHE)
Form8-K, current report
Filed with the SECApr 17, 2024, 10:15 AM ET
Accession number0001562762-24-000090

Items reported: 2.01 Acquisition or Disposition Completed

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 17, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.